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Pre-irradiation intravenous administration of the radioprotective
drug S-2-t3-aminopropylamino]ethylphosphorothloic acid (WR-2721) has
potential value in radiotherapy because it doubles the radiation
resistance of normal mouse tissues while affording only minimal protection
to tumors (1). Deficient deposition of WR-2721 in tumor tissue has recently
been demonstrated (2,3), and this is thought to be a major reason for the
preferential protection of normal tissues by the drug.
Data originally obtained in our etudy using the mouse and rat (2)
indicated that the tissue distribution of WR-2721 was possibly more
closely related to dose per unit surface area than to dose per unit weight.
To test this hypothesis an interspecies comparison of the tissue distri-
35bution of S-labelsd WR-2721 was carried out in normal mice, rats, rabbits,
and dogs at 15 and 30 minutes after intravenous administration.
The animals used were male C57BL/6 mice, male Buffalo rats, female
Hew Zealand white rabbits, and both sexes of laboratory grade beagle
dogs. (Results were pooled since no sex difference was evident.) Both
35
unlabeled and ' S-labeled NR-2721 (9.4 yCi/mg) were synthesized according
to the method of Piper et al. (4) and were assessed to be of greater than
purity (5). The appropriate mixture of labeled and unlabeled WR-2721
was dissolved in distilled water immediately before use. Mice, rats,
35 35
and rabbits received 10 uCi S/kg and dogs received 20 yCi S/kg. Mice
and rats were killed by exsanguination following light ether anesthesia,
while rabbits and dogs were given an intravenous overdose of sodium
pentobarbital. Tissue processing, solubilization, and counting have been
described elsewhere (2).
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The WR-2721 dose administered to each species was that which would
produce the same tissue concentrations in all species, if drug dose per
unit surface area were the sole factor in determining tissue con-
centrations. Since the respective surface area correction factors are
1.0 for the mouse, 1.43 for the rat, 2.74 for the rabbit, and 4.82 for
the dog (6), the administered doses, in terms of dose per unit body
weight, were 100 mg/kg for tha mouse, 70.0 mg/kg for the rat, 36.5 mg/kg
for the rabbit, and 20.8 mg/kg for the dog.
For purposes of analysis, x*e normalized the averaged WR-2721 tissue
concentrations (ug/g) for each species. A normalization factor for each
mouse tissue was derived which converted the concentration for each mouse
tissue to 100 yg/g; each "mouse tissue normalization factor" was then
multiplied by the observed concentration of the same tissue in the other
species. A log-log plot of these normalized values for each tissue as
a function of animal weight is given in Fig. 1 for the 15 minute data.
Data obtained at 30 minutes was similar. Theoretical lines describing
perfect "dose per unit surface area" and "dose per unit body weight"
relationships are included.
The data in Fig. 1 suggests that the surface area and body weight
exert equal effects on the tissue concentration of WR-2721. The results
further suggest that lower absolute doses of WR-2721 in the human, possibly
as low as 20 mg/kg, may provide a radioprotective effect equivalent to
that produced from 100 mg/kg in the mouse, i.e., a 50-80% increase in
radiation resistance.
-4
1. Yuhas, J.M. and Storer, J.B. (1969) J. Nat. Cancer Inst., _A2, 331-335
2. Washburn, L.C., et al. (1974) Radiat. Res., JS9, 475-483
3. Kollman, G., et al. (1973) Radiat. Res., 55, 603
4. Piper, J.R., et al. (1969) J. Med. Chern., 2,2, 236-243
5. Washburn, L.C. and Hayes, R.L. (1974) Anal. Chem., j>6, 2231
6. Paget, G.E. (1965) in Clinical Testing of New Drugs (Herrick, A.D.
and Cattell, A., eds.), pp. 31-39. Revere Publishing Co., Hew York
This study was supported by the Energy Research and Development Administration
under contract with Oak Ridge Associated Universities and Union Carbide
Corporation.
Presented at the Third Annual Meeting of the Southeastern Cancer Research
Association, October 2-4, 1975, Atlanta, Georgia.
nd
-5-
Lcgc
35
Fig. 1 Relationship of normalized tissue concentrations of S-labcled
WR-2721 to body weights in various tissues of the mouse, rat,
rabbit, and dog at 15 minutes postinjection.
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